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        The activation, proliferation, and recruitment 
of T cells to the lungs of allergic asthmatic pa-
tients have been shown to promote the im-
mune responses generally associated with this 
disease, such as airway Th2 cytokine produc-
tion, the recruitment/accumulation of eosino-
phils, and induction of pulmonary pathologies (  1  ). 
The importance of T lymphocytes in mouse 
models of allergic respiratory infl  ammation is 
also highlighted in studies showing that deple-
tion of T cells in allergen-provoked mice in-
hibits asthma pathologies, including eosinophil 
recruitment to the lungs (  2  ). Interestingly, al-
though eosinophil recruitment to the lung has 
been a defi  ning characteristic of allergic respi-
ratory infl   ammation, occurring, for example, 
even in mild forms of asthma (  3  ), causative links 
between pathologies and specifi  c eosinophil-
mediated activities have remained unresolved 
(e.g., reference   4   vs. reference   5  ), with some 
clinical studies even   discounting signifi  cant roles 
for eosinophils (  6  ). Instead, most papers have 
implied a nearly unidirectional immune regu-
latory mechanism by which T cells promote 
the infl  ammation of asthma with the role of 
eosinophils remaining ambiguous and the sub-
ject of debate. This ambiguity results, in part, 
because the defi  nition and signifi  cance of unique 
eosinophil eff  ector functions have also remained 
debatable, with the primary role of eosinophils 
restricted to destructive eff  ector cells mediating 
tissue damage (  7  ). Specifi  cally, the dominant 
eff  ector functions ascribed to eosinophils have 
been hypothesized to result from the produc-
tion of reactive oxygen species (i.e., respiratory 
burst) and the release of cationic granule pro-
teins (i.e., eosinophil degranulation) (  8  ). This 
perspective is so pervasive that it often excludes 
discussion of other eff  ector functions (for re-
view see reference   9  ). 
  Recent studies of eosinophils and their as-
sociated activities have nonetheless revealed a 
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  The current paradigm surrounding allergen-mediated T helper type 2 (Th2) immune re-
sponses in the lung suggests an almost hegemonic role for T cells. Our studies propose an 
alternative hypothesis implicating eosinophils in the regulation of pulmonary T cell re-
sponses. In particular, ovalbumin (OVA)-sensitized/challenged mice devoid of eosinophils 
(the transgenic line     PHIL    ) have reduced airway levels of Th2 cytokines relative to the OVA-
treated wild type that correlated with a reduced ability to recruit effector T cells to the 
lung. Adoptive transfer of Th2-polarized OVA-specifi  c transgenic T cells (OT-II) alone into 
OVA-challenged     PHIL     recipient mice failed to restore Th2 cytokines, airway histopatholo-
gies, and, most importantly, the recruitment of pulmonary effector T cells. In contrast, the 
combined transfer of OT-II cells and eosinophils into     PHIL     mice resulted in the accumula-
tion of effector T cells and a concomitant increase in both airway Th2 immune responses 
and histopathologies. Moreover, we show that eosinophils elicit the expression of the Th2 
chemokines thymus- and activation-regulated chemokine/CCL17 and macrophage-derived 
chemokine/CCL22 in the lung after allergen challenge, and blockade of these chemokines 
inhibited the recruitment of effector T cells. In summary, the data suggest that pulmonary 
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unequivocally show the relationship between eosinophils and 
the development of pulmonary Th2 immune responses in a 
mouse model of acute respiratory infl  ammation. Specifi  cally, 
  PHIL   mice and C57BL/6J wild-type controls were sensitized 
(days 0 and 14) with OVA/Alum and challenged with an 
OVA aerosol on days 24, 25, and 26 (control animals re-
ceived saline alone), and endpoints of pathology were ana-
lyzed on day 28 (Fig. S1 A, available at http://www.jem
.org/cgi/content/full/jem.20071840/DC1). In contrast to 
wild-type controls,   PHIL   mice were unable to induce a pul-
monary eosinophilia (  Fig. 1 A  ) or elevate bronchoalveolar la-
vage (BAL) Th2 cytokines (IL-4, IL-5, and IL-13) in response 
to allergen (  Fig. 1 B  ).   Previous hypotheses characterizing the 
immune responses in the lung after allergen provocation have 
implicated T cells in the production of Th2 cytokines (  1  ). 
Furthermore, mouse models of chronic allergic asthma have 
correlated reduced airway eosinophilia in CCR3 knockout 
mice and eosinophil-defi  cient mice with reduced lympho-
cyte infi  ltration and hindered Th2 pathologies (  12  ). This led 
us to determine the numbers of lymphocytes accumulating in 
the airways of allergen-provoked   PHIL   mice relative to wild-
type animals as a possible explanation of the reduced Th2 
  responses in the absence of eosinophils. These assessments 
showed that lymphocyte numbers in the airways of OVA-
treated   PHIL   mice were signifi  cantly reduced as compared 
with similarly treated wild-type controls (  Fig. 1 C  ). Our 
studies also demonstrated that the decreased lymphocyte in-
fi  ltration into the airways of   PHIL   mice was not transient and 
that the loss of eosinophils had consequences for the extended 
kinetics of lymphocyte accumulation. Specifi  cally,   PHIL   and 
wild-type controls were allergen challenged and analyzed at 
diff  erent time points after allergen challenge (Fig. S1 B). BAL 
cell accumulation data demonstrated that the eosinophil infi  l-
tration of the airways in wild-type mice occurred maximally 
4 d after allergen challenge and were resolved (i.e., returned 
to baseline levels) within 2 wk (  Fig. 1 D  ). In contrast, al-
though lymphocyte infi  ltration of the lungs in wild-type 
mice followed a similar kinetic pattern early (i.e., achieving a 
maximum at     4 d after challenge), these cells remained ele-
vated during the subsequent 15-d period after allergen chal-
lenge (  Fig. 1 E  ). However, these data also showed that in the 
absence of eosinophils, the kinetics of lymphocyte accumula-
tion in the airways are disrupted with neither the maximal 
increase at 4 d after allergen challenge nor the sustained ele-
vation of lymphocytes occurring in OVA-treated   PHIL   mice 
(  Fig. 1 E  ). Thus, allergen-mediated eosinophil recruitment to 
the lungs of mice appears to be necessary for the pulmonary 
recruitment and accumulation of lymphocytes, and the cor-
responding production of BAL Th2 cytokines. 
  OVA-treated   PHIL   mice fail to accumulate both CD4  +   
and CD8  +   T cells in the airways, lungs, and regional 
draining lymph nodes 
  The lack of signifi  cant accumulation of total lymphocytes and 
the reduced Th2 cytokine expression suggested the potential 
that both CD4  +   and CD8  +   T cell accumulation in the lungs 
wealth of complexity that extends beyond the notion that 
these leukocytes are primarily a delivery system for their cat-
ionic and toxic granule proteins. Two areas of research are 
primarily responsible for this changing paradigm. First, studies 
in the mouse have overwhelmingly shown both the absence 
of extensive eosinophil degranulation in most Th2 infl  amma-
tory models and the lack of any signifi  cant contribution by 
eosinophil granule proteins to the disease pathologies asso-
ciated with pulmonary allergen provocation (  10, 11  ). Yet, in 
studies using mice congenitally defi  cient of eosinophils, the 
unique absence of these granulocytes leads to a diminution 
of Th2 immune responses in both acute and chronic models 
of allergen provocation (  5, 12  ). Second, studies assessing 
immune responses associated with allergen provocation or 
parasite infection have implicated eosinophils as potential im-
mune regulatory cells capable of modulating T cell responses 
and, in turn, local tissue infl  ammation. For example, eosino-
phils have been shown to express key mediators of T cell 
  inhibition, activation, and polarization, such as IL-2, IL-4, 
indoleamine 2,3-dioxygenase, TGF-    , and IL-10 (  9  ). In addi-
tion, recent studies have highlighted the potential role of 
eosinophils as antigen-presenting cells as part of immune re-
sponses leading to T cell proliferation/activation in response 
to allergen provocation in the lung (  13  ), as well as in response 
to parasite infection (  14  ). Collectively, these studies suggest 
that eosinophils may be critical cells regulating Th2 immune 
responses in the lung after allergen provocation, and their 
role may even supercede the functions of T cells (for review 
see reference   15  ). 
  In this study, we provide support for the novel hypothesis 
that a primary role of eosinophils in allergic pulmonary re-
sponses is to elicit the localized recruitment/accumulation of 
eff  ector T cells in the lung. In particular, our data using the 
eosinophil-defi  cient transgenic strain of mice known as   PHIL   
(  5  ) and two independent models of allergic respiratory infl  am-
mation showed that the attenuation of Th2 immune responses 
in the absence of eosinophils (i.e., relative to eosinophil-
  suffi   cient wild-type animals) was accompanied by a concomitant 
and specifi  c loss of T cells from the lung and regional draining 
lymph nodes. Moreover, using adoptive cell transfer of both 
eosinophils and allergen-specifi  c activated eff  ector T cells, we 
were able to show that eosinophil-mediated activities were 
required for the recruitment of T cells to the lung, and that 
one of the mechanisms of this recruitment is likely through 
the induced production of the Th2-chemoattracting chemo-
kines   thymus- and activation-regulated chemokine (TARC)/
CCL17 and   macrophage-derived chemokine (MDC)/CCL22 
in the lung. 
    RESULTS   
  The reduction of allergen-induced pulmonary pathologies 
in OVA-treated   PHIL   mice is accompanied by a corresponding 
decrease in pulmonary Th2 immune responses 
  We used a novel eosinophil-defi  cient transgenic line (  PHIL  ), 
which is congenitally devoid of eosinophils without disturb-
ing the production of other hematopoietic lineages (  5  ), to JEM VOL. 205, March 17, 2008 
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mice failed to display allergen-mediated increases in either 
CD4  +   or CD8  +   T cells in the airways, lungs, and regional 
draining lymph nodes. This lack of T cell accumulation 
was restricted to the lungs and lymph nodes, as spleens from 
these mice did not statistically diff  er in their total numbers of 
CD4  +   and CD8  +   T cells, suggesting an inability to accumu-
late these cells specifi  cally to pulmonary compartments after 
OVA provocation. 
may be altered in OVA-treated   PHIL   mice (  15  ). Leukocytes 
from the airways (i.e., BAL), whole-lung digests, caudal 
mediastinal lymph nodes, and splenocytes from OVA-sensitized/
aerosol-challenged   PHIL   and wild-type animals were ana-
lyzed by fl  ow cytometry for populations of CD4  +   and CD8  +   
T cells (  Fig. 2  ).   In contrast to OVA-treated wild-type con-
trols, which displayed signifi  cant increases in both T cell sub-
types relative to saline control groups, OVA-treated   PHIL   
    Figure 1.         Allergen-mediated pulmonary Th2 infl  ammatory responses and lymphocyte infi  ltration of the lung are attenuated in the 
absence of eosinophils.   Wild-type and   PHIL   mice were subjected to the acute OVA sensitization/challenge (control animals received saline alone) 
  protocol described in Materials and methods and Fig. S1 A. (A) Immunohistochemistry using an anti  –  mouse MBP rat mAb (black) demonstrated the 
absence of infi  ltrating eosinophils in OVA-treated   PHIL   mice relative to wild-type controls. Bar, 100   μ  m. (B) Allergen-induced increases in BAL Th2 cyto-
kine levels (as assessed by ELISA) failed to occur in   PHIL   mice as compared with wild-type controls. (C) Assessments of BAL cellularity demonstrated 
that lymphocyte numbers are signifi  cantly reduced in OVA-treated   PHIL   mice relative to wild-type controls. Kinetic assessments (Fig. S1 B) of OVA-
induced eosinophil (D) and lymphocyte (E) accumulation in the BAL of wild-type versus   PHIL   mice 1, 4, and 15 d after OVA challenge showed that in 
the absence of eosinophils, the early and sustained infl  ux of lymphocytes into the lung after allergen challenge is abolished. Data presented are the 
means   ±   SE. *, P   <   0.05.     702 EOSINOPHILS INDUCE ALLERGEN-MEDIATED T CELL RECRUITMENT TO THE LUNG | Jacobsen et al.
in wild-type control animals. The lungs of OVA-treated  PHIL   
mice displayed a signifi  cant reduction in accumulating CD4  +  /
CD25  +   T cells and CD4  +  /NK1.1  +   NKT cells (  Fig. 3 A  ) rela-
tive to OVA-treated wild-type controls.   Furthermore, exam-
ination of the T cell subtypes in OVA-treated   PHIL   versus 
wild-type mice showed that signifi  cant accumulation of ef-
fector T cells (CD4  +  /CD62L      /lo  /CD44  hi  ) in the lungs and 
regional draining lymph nodes occurred only in wild-type 
animals and was absent in OVA-treated   PHIL   mice (  Fig. 3 B  ). 
Interestingly, the regional draining lymph nodes of OVA-
treated   PHIL   mice also displayed a signifi  cant reduction in 
memory (CD4  +  /CD62L  med/hi  /CD44  hi  ) but not naive (CD4  +  /
CD62L  hi  /CD44      /lo  ) T cells (  Fig. 3 B  ). Furthermore, assess-
ments of CCR7 expression (i.e., a memory/eff  ector T cell 
marker that appears to participate in the recruitment of 
T cells to lymph nodes in allergen challenge models [  20  ]) also 
demonstrated that CD4  +  /CCR7  +   T cells were reduced in 
OVA-treated   PHIL   draining lymph nodes as compared with 
wild-type controls (0.65   ±   0.12 vs. 2.18   ±   0.35   ×   10  5  , re-
spectively; P   <   0.05). These phenomena appear to be specifi  c 
to the pulmonary compartments, as splenocyte numbers of 
eff  ector, memory, and naive T cells are unchanged between 
OVA-treated   PHIL   and wild-type control animals. Thus, the 
loss of these T cell populations in the lungs and regional 
draining lymph nodes of OVA-treated   PHIL   mice suggested 
that the absence of eosinophils led to the loss of T cell prolif-
eration/activation, a loss of recruitment pathways leading to 
T cell accumulation in the lung, or both. 
  Several previous studies have demonstrated that eosinophils 
participate in the proliferation/activation of naive and memory 
T cells into eff  ector T cells (e.g., through antigen presentation 
and co-stimulation [  14, 21  –  23  ]), which may be evident by the 
reduced numbers of memory/eff  ector T cells in the regional 
draining lymph nodes of OVA-treated  PHIL   mice. Conversely, 
the impaired recruitment of all T cell   subsets (CD8  +  , CD4  +  /
CD25  +  , CD4  +  /NK1.1  +  , and CD4  +  /CD62L      /lo  /CD44  hi  ) into 
the lung may implicate a larger and more profound failure in 
T cell recruitment, extending beyond potential eosinophil 
activities mediating allergen-specifi  c T cell proliferation/acti-
vation. We assessed the potential of each of these eosinophil-
dependent mechanisms as contributors to pulmonary T cell 
accumulation in two independent experiments. 
  First, in eosinophil-mediated T cell proliferation/activa-
tion, our inability to recruit OVA-specifi  c Th2 cells after the 
adoptive transfer of eosinophils into the airways of OVA-
sensitized and -challenged   PHIL   mice (unpublished data) 
suggested that eosinophils may be required for Th2 cell 
generation. This potential pathway was further defi  ned in 
ex vivo studies demonstrating that eosinophils were required 
for the elaboration of Th2 immune responses after allergen 
challenge. Specifi  cally, splenocytes from OVA-sensitized or 
OVA-sensitized and -challenged   PHIL   mice (splenocytes 
from wild-type animals were used as controls) were isolated, 
and their abilities to elaborate IL-13 were assessed after co-
culture with media alone, OVA, or a nonspecifi  c stimulus (i.e., 
cross-linking of surface receptors with anti-CD3 and -CD28 
  Eosinophil-dependent T cell activation and recruitment 
each represent mechanisms leading to the reduced 
pulmonary T cell accumulation in OVA-treated   PHIL   mice 
  Mouse models of allergen-mediated Th2 infl  ammation have 
been attributed to the activities (e.g., Th2 cytokine expression) 
of particular subsets of CD4  +   T cells in the lung (e.g., CD4  +  /
CD25  +   cells [i.e., proliferating T cells and/or regulatory T 
cells; reference   16  ], NKT cells [CD4  +  /NK1.1  +  ; reference   17  ]), 
and eff  ector T cells (CD4  +  /CD62L      /lo  /CD44  hi   [  18  ]), as well 
as CD8  +   T cells (  19  ). To defi  ne the extent of the eff  ects on 
pulmonary T cell recruitment in the absence of eosinophils, 
the numbers of CD4  +   T cells within each subset were  determined 
in OVA-treated   PHIL   mice relative to their accumulation 
    Figure 2.         The OVA-induced accumulation of both CD4  +   and CD8  +   
T cells is signifi  cantly reduced in the airways, lungs, and regional 
draining lymph nodes in the absence of eosinophils.   Flow  cytometric 
assessments of leukocytes derived from BAL, whole-lung digests, and lung 
draining lymph nodes showed that in the absence of eosinophils (i.e., 
  PHIL ),  signifi  cant reductions of both CD4  +   and  CD8 +   T cell subtypes are 
observed in all three pulmonary compartments after OVA provocation. 
This observation was shown to be lung specifi  c, as assessments of the 
splenic cellularity of these mice showed no difference in either CD4  +   or 
CD8  +   T cell numbers between OVA-treated wild-type and   PHIL   mice. 
In each case, single-cell suspensions were counted, and the fractional 
composition of each suspension was assessed by fl  ow cytometry based 
initially on scatter to establish a lymphocyte gate, and then stained with 
antibodies for the T cell markers CD3, CD4, and CD8. Data presented are 
the means   ±   SE. *, P   <   0.05.     JEM VOL. 205, March 17, 2008 
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in OVA-treated   PHIL   mice and is part of our ongoing studies 
further characterizing the role of eosinophils in activation/
co-stimulation of T cells (unpublished data). 
  Second, in eosinophil-dependent recruitment/accumulation 
of T cells to the lung, the impaired accumulation of multiple 
T cell subsets in OVA-treated   PHIL   mice (i.e., CD8  +  , CD4  +  /
CD25  +  , CD4  +  /NK1.1  +  , and CD4  +  /CD62L      /lo  /CD44  hi   T cells) 
suggested that eosinophils may be required for generalized 
pathways that promote localized T cell recruitment. The ability 
of all of these T cell subtypes to express CCR4 (  24  –  26  ) also 
provides a potential mechanism by which eosinophils would 
be able to mediate the recruitment of T cells to sites of Th2 
infl  ammation. Several lines of evidence further suggested that 
antibodies;   Fig. 3 C  ). These studies demonstrated that the 
absence of eosinophils (i.e.,   PHIL   mice) leads to a defect 
in OVA-specifi  c Th2 cytokine production. That is, this ob-
served defect was restricted to OVA exposure ex vivo, as 
T cell responses to a nonspecifi  c stimulus were equivalent 
between splenocytes isolated from   PHIL   versus wild-type mice. 
Signifi  cantly, this OVA-specifi  c defect in IL-13 production 
was limited to animals that were both OVA-sensitized and 
aerosol-challenged, suggesting an impairment in the activa-
tion/proliferation of OVA-specifi  c memory T cells into 
polarized Th2 eff  ector T cells in OVA-treated   PHIL   mice. 
This immunoregulatory role for eosinophils represents a likely 
mechanism contributing to the attenuated immune responses 
    Figure 3.         OVA-treated   PHIL   mice display reduced accumulation of CD4  +   T cell subtypes, intrinsic defects in allergen-specifi  c T cell 
  activities, and the loss of allergen-induced TARC and MDC expression.   (A) Determinations of T cell subsets for whole-lung digests, regional draining 
lymph nodes, and spleen were completed by examining total cell numbers between OVA-treated wild-type versus   PHIL   mice. OVA-treated wild-type versus 
  PHIL   mice show that CD4  + /CD25 +   (T regulatory/proliferation) and CD4  + /NK1.1 +   (NKT) cells were elevated in the lungs of OVA-treated wild-type mice but 
not in OVA-treated PHIL mice. (B) Effector T cells (CD4  + /CD62L    /lo /CD44 hi  ) were reduced in lungs and caudal mediastinal (i.e., regional draining) lymph 
nodes. Furthermore, caudal mediastinal lymph nodes also had reduced numbers of memory T cells (CD4  + /CD62L med/hi /CD44 hi  ). Naive T cell (CD4  + /CD62L hi /
CD44     /lo  ) numbers remained unchanged between wild-type and   PHIL   mice in both the spleen and pulmonary compartments. (C) Splenocytes from sensi-
tized and sensitized/challenged   PHIL   and wild-type mice were cultured for 96 h in the presence of media alone, 200   μ  g/ml OVA, or cross-linked anti-
CD3/-CD28. Measurement of IL-13 in the supernatant revealed an inability for sensitized/challenged   PHIL   splenocytes to generate wild-type levels of this 
cytokine. (D) BAL chemokine levels were determined by ELISA from wild-type and   PHIL   mice subjected to the acute OVA sensitization/challenge protocol 
described in Fig. S1 A. Signifi  cantly, although substantive increases in MDC and TARC were observed in the BAL of OVA-treated   eosinophil-suffi  cient wild-
type animals (i.e., relative to saline control mice), increased levels of these Th2 cell chemokines did not occur in the lungs of OVA-treated   PHIL   mice (i.e., in 
the absence of eosinophils). Kinetic assessments (Fig. S1 B) of MDC and TARC in the BAL of post  –  OVA-challenged wild-type mice showed that the appear-
ance of these Th2 cell chemokines correlated with the levels of OVA-induced airway eosinophilia. Data presented are the means   ±   SE. *, P   <   0.05.     704 EOSINOPHILS INDUCE ALLERGEN-MEDIATED T CELL RECRUITMENT TO THE LUNG | Jacobsen et al.
and eosinophil-defi  cient   PHIL   recipient mice were either 
injected (i.v.) once with PBS or 1.5   ×   10  7   OT-II cells on day 0 
of this protocol, followed by intranasal (i.n.) administration 
of 20   μ  l of a 1   μ  g/  μ  l OVA solution prepared in saline on pro-
tocol days 0, 1, and 2 (  Fig. 4 A  ).   OVA-induced responses 
in these recipient mice were assessed on day 4 as the elabora-
tion of Th2 cytokine expression and/or the development of 
allergen-induced pulmonary histopathology. Because of the 
eosinophil-defi  cient character of   PHIL   recipient mice and, 
therefore, the potential of artifactual events associated with 
the adoptive transfer of Th2-polarized OVA-specifi  c eff  ector 
T cells into these recipients, several control studies were per-
formed to ensure that the proliferation and cell-surface acti-
vation profi  le of the adoptively transferred OT-II cells were 
not altered relative to wild-type control mice. For example, 
OT-II cells were labeled with the fl  uorescent marker CFSE, 
and the proliferation and cell-surface activation markers of 
these cells were assessed in OVA-challenged   PHIL   versus wild-
type mice after adoptive transfer. As shown in Fig. S2 (available 
at http://www.jem.org/cgi/content/full/jem.20071840/DC1), 
OT-II cell proliferation (as judged by the dilution of CFSE 
staining intensity) was similar between   PHIL   and wild-type 
mice, indicating that eosinophils were not required for in 
vivo proliferation of these T cells. In addition, these CFSE-
labeled cells maintained their memory (CD4  +  /CD62L  med/hi  /
CD44  hi  )/eff  ector (CD4  +  /CD62L      /lo  /CD44  hi  ) T cell surface 
phenotypes in OVA-challenged   PHIL   animals after adoptive 
transfer (Fig. S3). 
  A total of three independent experimental groups of 
OVA-challenged animals was examined using this adoptive 
transfer model to defi  ne the relative roles of eosinophils in 
the development of Th2 pulmonary immune/infl  ammatory 
responses (  Fig. 4 A  ). Group I consisted of OVA-naive wild-
type and   PHIL   recipient mice receiving OT-II cells i.v. (con-
trols received PBS vehicle alone) on protocol day 0, and saline 
intratracheally (i.t.) on protocol days 0, 1, 2, and 3. Group II 
consisted of OVA-naive   PHIL   recipient mice after adoptive 
transfer (i.t.) of 10  7   eosinophils on protocol days 0, 1, 2, and 3. 
The success of eosinophil adoptive transfer was confi  rmed 
by the recovery of BAL eosinophils in hematoxylin and 
eosin  –  stained cytospin preparations (Fig. S4 A, available at 
http://www.jem.org/cgi/content/full/jem.20071840/DC1) 
and the identifi  cation of tissue-infi  ltrating eosinophils using 
major basic protein (MBP)  –  specifi  c immunohistochemistry 
(Fig. S4 B) on protocol day 4. Finally, group III consisted of 
OVA-naive   PHIL   recipient mice receiving both OT-II cells 
(i.v.) on protocol day 0 and adoptively transferred (i.t.) eosin-
ophils on protocol days 0, 1, 2, and 3. 
  These studies showed that the adoptive transfer of OT-II 
cells (group I) or eosinophils (group II) alone into OVA-
challenged   PHIL   recipient mice were each insuffi   cient for the 
development of allergen-induced Th2 pulmonary responses 
(  Fig. 4 B  ). Moreover, OVA-naive wild-type and   PHIL   mice 
receiving OT-II cells by i.v. and saline by i.n. challenge did 
not display an increase in either Th2 cytokine levels or in-
duced histopathologies (not depicted). In contrast, adoptive 
the CCR4 chemokine ligands TARC and MDC were likely 
candidates by which lung-infi  ltrating eosinophils may elicit 
the recruitment of T cells: (a) TARC and MDC have been 
described as part of the mechanisms mediating T cell recruit-
ment in several mouse models of Th2 infl  ammation (  26  ); 
(b) induced airway epithelial and macrophage expression of 
TARC and MDC correlates with the pulmonary eosinophilia 
asso  ciated with allergic respiratory infl  ammation (  27  ), and 
the levels of each of these chemokines are elevated in the 
sputum of asthmatic patients as compared with otherwise 
normal individuals (  28  ); and (c) microarray analyses of gene 
expression comparing mRNA levels from BAL-derived eo-
sinophils of OVA-treated mice versus blood eosinophils of 
OVA-naive animals showed that TARC and MDC were each 
signifi  cantly elevated (greater than fourfold) in BAL-derived 
eosinophils (unpublished data) (  29  ). 
  Assessments of MDC and TARC levels in the BAL of 
OVA-treated   PHIL   and wild-type mice confi  rmed that the 
expression of these chemokines was linked to the presence of 
pulmonary eosinophils. That is, OVA-sensitized/aerosol-
  challenged wild-type animals displayed a signifi  cant elevation 
(relative to saline controls) in BAL levels of MDC and TARC 
that did not occur in OVA-treated   PHIL   mice (  Fig. 3 D  ). 
In contrast, the BAL levels of other chemokines such as eotaxin-1 
and -2 were not statistically diff  erent between   PHIL   and wild-
type mice (not depicted). Kinetic assessments of MDC and 
TARC expression in OVA-treated wild-type animals showed 
that this expression correlated with the induced pulmonary 
eosinophil infi  ltrate, with BAL chemokine levels closely paral-
leling BAL eosinophilia after OVA challenge (  Figs. 3 E  ). 
Signifi  cantly, the levels of each of these Th2 cell chemokines 
in OVA-treated   PHIL   mice were indistinguishable from saline 
controls throughout the time period examined, suggesting that 
eosinophil-induced expression of MDC and TARC may be a 
contributing (possibly responsible) mechanism for allergen-
mediated T cell recruitment to the lung. 
  Restoration of the Th2 infl  ammatory lung responses 
of OVA-treated   PHIL   mice requires the adoptive transfer of 
both activated OVA-specifi  c effector T cells and eosinophils 
  Adoptive cell transfers of OVA-specifi  c Th2-polarized T cells 
into OVA-challenged   PHIL   recipient mice were performed 
to demonstrate the role of eosinophils in T cell recruitment 
and the development of Th2-driven immune responses 
in the lung. Specifi  cally, adoptive transfer of OVA-specifi  c 
Th2-polarized eff  ector T cells allowed us to bypass require-
ments of eosinophil-dependent mechanisms of T cell prolif-
eration/activation, testing the hypothesis that eosinophils 
contribute to the development of allergen-mediated Th2 
immune responses through the recruitment of OVA-specifi  c 
eff  ector T cells. These studies capitalized both on our previ-
ous experience with eosinophil adoptive transfer (  30  ) as well 
as the availability of OVA-specifi  c TCR transgenic mice 
that allows the isolation/transfer of in vitro Th2-polarized 
OVA-specifi  c eff  ector T cells (OT-II). In this allergen chal-
lenge model system, naive eosinophil-suffi   cient wild-type JEM VOL. 205, March 17, 2008 
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mice (group III) resulted in goblet cell metaplasia/airway 
epithelial cell mucin accumulation that was comparable to 
that observed in OVA-challenged wild-type mice receiving 
OT-II cells (  Fig. 4 C  ). These observations suggest that the 
eosinophil activities required for the development of Th2 re-
sponses extend beyond the potential eff  ects on the proliferation/
activation of OVA-specifi  c eff  ector T cells. 
  Eosinophils mediate T cell recruitment to the lung 
after adoptive transfer into OVA-challenged   PHIL   mice 
by an MDC/TARC-dependent mechanism 
  The allergen-induced pulmonary pathologies resulting from   
the combined adoptive transfer of OT-II cells and eosinophils 
transfer of both OT-II cells and eosinophils into   PHIL   mice 
(group III) led to signifi  cant increases in BAL levels of the 
Th2 cytokines (e.g., IL-5 and IL-13;   Fig. 4 B  ); IL-4 was not 
signifi  cantly elevated above baseline. The development of 
Th2-driven histopathologies in each of these groups of mice 
paralleled the pattern of induced Th2 cytokine expression. 
That is, administration of either OT-II cells (group I) or eo-
sinophils (group II) alone into OVA-challenged   PHIL   mice 
failed to result in the development of histopathologies such 
as the peribronchial aggregation of eosinophils (Fig. S4 B) and 
goblet cell metaplasia/airway epithelial cell mucin accumu-
lation (  Fig. 4 C  ). However, the adoptive transfer of both 
OT-II cells and eosinophils into OVA-challenged   PHIL   
    Figure 4.         Adoptive transfer of both OVA-specifi  c Th2-polarized effector T cells (OT-II) and eosinophils are required to generate Th2 
pulmonary pathologies in   PHIL   mice.   (A) Schematic timeline of the acute OVA challenge protocol associated with the adoptive transfer studies of Th2-
polarized OVA-specifi  c T cells (OT-II) and eosinophils. (B) Th2 BAL levels of the cytokines IL-13 and IL-5 (IL-4 was undetectable) were assessed by ELISA. 
  PHIL   mice receiving either OT-II cells (group I) or eosinophils (group II) alone showed no pathologies, whereas adoptive transfer of OT-II cells in   PHIL   mice 
together with the restoration of the absent pulmonary eosinophilia (group III) promoted signifi  cant increases in the BAL levels of the Th2 cytokines IL-13 
and IL-5. Data presented are the means   ±   SE. *, P   <   0.05. (C) Assessments of goblet cell metaplasia and airway epithelial cell mucin accumulation by PAS 
staining of lung sections (purple) revealed that only the adoptive transfer of both OT-II cells and eosinophils to   PHIL   mice was capable of reconstituting 
this allergen-induced histopathology.   PHIL  /Eos, OVA-provoked   PHIL   mice after i.t. transfer of eosinophils;   PHIL  /OT-II, OVA-provoked   PHIL   mice  after 
OT-II cell transfer;   PHIL  /OT-II/Eos, OVA-provoked   PHIL   mice after adoptive transfer of both OT-II cell (i.v.) and eosinophils (i.t.); WT/OT-II, OVA-provoked 
wild-type mice after OT-II cell transfer. Bar, 100   μ  m.     706 EOSINOPHILS INDUCE ALLERGEN-MEDIATED T CELL RECRUITMENT TO THE LUNG | Jacobsen et al.
the pattern of CD4  +   T cell accumulation observed in these 
mice (  Fig. 5 B  ). That is,   PHIL   mice receiving only OT-II 
cells (group I) or eosinophils (group II) were unable to elevate 
MDC and TARC to the levels observed in OVA-challenged 
wild-type mice receiving OT-II cells, whereas the adminis-
tration of both OT-II cells and eosinophils to OVA-challenged 
  PHIL   mice was suffi   cient to return these chemokines to wild-
type levels. 
  We performed antibody blocking studies to antagonize 
the activities of MDC and TARC after adoptive cell transfer 
to demonstrate that the recruitment of T cells in group III 
mice was dependent on the observed eosinophil-induced ex-
pression of these Th2 chemokines. Specifi  cally, in addition to 
the assessments of CD4  +   T cell recruitment to the lung after 
adoptive transfer of either OT-II cells (group I) or eosino-
phils (group II) alone, OVA-challenged   PHIL   mice adop-
tively transferred with both OT-II cells and eosinophils 
(group III) were treated with either isotype control antibody 
or neutralizing antibodies to TARC and MDC on days 0, 1, 
2, and 3 of the protocol outlined in   Fig. 4 A   and Materials and 
(group III) suggested that eosinophil-dependent recruitment 
of T cells may be a responsible mechanism for the immune/
infl  ammatory responses that occur in the lungs of allergen-
challenged mice. Indeed, unlike the transfer of individual 
leukocyte populations (group I and II), the concurrent adop-
tive transfer of both OT-II cells and eosinophils (group III) 
resulted in a signifi  cant increase in the recruitment of CD4  +   
T cells in the airways and lung tissue of OVA-challenged 
  PHIL   mice (  Fig. 5 A  ); CD8  +  , CD4  +  /CD25  +  , and CD4  +  /
NK1.1  +   T cell profi  les were similar to CD4  +   T cell pro-
fi  les (not depicted).   Thus, adoptive transfer of eosinophils in 
the presence of OVA-specifi  c Th2 eff  ector T cells restored the 
recruitment of T cell subsets to the lung concurrent with the 
observed increases in Th2 immune-mediated pathologies. 
  To demonstrate that the recruitment of T cells to the lungs 
of OVA-challenged mice after adoptive cell transfer corre-
lated with MDC and TARC expression, we measured the 
BAL levels of these chemokines in each of the adoptive trans-
fer groups of mice. Signifi  cantly, the expression of MDC and 
TARC in the BAL of mice after adoptive cell transfer paralleled 
    Figure 5.         Eosinophil-dependent expression of TARC and MDC is required for CD4  +   T cell recruitment to the lungs of allergen-challenged 
  PHIL   mice.   (A) Wild-type and   PHIL   mice were adoptively transferred with either OT-II cells (group I) or eosinophils (group II) alone, or with both eosino-
phils and OT-II cells (group III). Assessments of the CD4  +   T lymphocyte cellularity in BAL and whole-lung digests showed that in contrast to adoptive 
transfer of either OT-II cells (group I) or eosinophils (group II) alone, adoptive transfer of OT-II cells in   PHIL   mice together with the restoration of the ab-
sent pulmonary eosinophilia (group III) promoted OVA-induced CD4  +   T cell accumulation in the lung. (B) ELISA measurements of these samples showed 
that BAL TARC and MDC levels are restored to wild-type levels in   PHIL   mice receiving both eosinophils and OT-II cells (group III). (C) Groups of mice were 
treated as in A, with the exception that group III mice were additionally administered either control polyclonal goat antibody (Isotype Control Ab) or neu-
tralizing antibodies to TARC and MDC (   -TARC/   -MDC) on days 0, 1, 2, and 3. Whole-lung digests were analyzed for CD4  +   T cell populations by fl  ow cy-
tometry. Horizontal bars represent means. Data presented are the means   ±   SE. *, P   <   0.05.     JEM VOL. 205, March 17, 2008 
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tions, as well as their requirement for a threshold level of eo-
sinophils, are responsible for many of the diffi   culties associated 
with the interpretation of results from both earlier mouse-
model studies of allergic infl   ammation and clinical studies 
of asthma patients that target eosinophils. For example, the 
partial eosinophil defi  ciency of IL-5      /      mice after OVA 
sensitization/challenge (    90% reduction relative to wild-type 
mice) is likely only to attenuate and not abolish eosinophil-
mediated eff  ects on T cells. This, in part, may explain the 
diff  erences in allergen-induced pulmonary infl  ammation that 
occurred in IL-5      /      mice among diff  erent studies (e.g., refer-
ence   34   vs. reference   35  ). Indeed, a requirement for a thresh-
old level of recruited eosinophils was suggested in studies 
examining the allergic respiratory infl  ammation in OVA-
treated IL-5      /      mice relative to OVA-treated IL-5/eotaxin-1 
double-knockout (IL-5      /     /eotaxin-1      /     ) animals. That is, 
although the partial loss of eosinophils failed to prevent 
OVA-induced infl  ammatory responses in IL-5      /     , these re-
sponses were abolished in IL-5      /     /eotaxin-1      /      mice that 
had a complete ablation of pulmonary eosinophils (  36  ). The 
demonstrated inability to completely eliminate lung tissue 
eosinophils among human subjects receiving anti  –  IL-5 thera-
peutics may also represent a confounding issue that has com-
plicated conclusions from clinical studies of asthma patients 
(  6, 37, 38  ). These observations suggest that together with 
potential activities on T cell proliferation/activation and de-
structive eff  ector activities mediated by granule protein re-
lease, the additional capability of eosinophils to mediate 
eff  ector T cell accumulation in the lung may provide yet 
another mechanism by which eosinophils initiate and maintain 
the immune/infl  ammatory responses associated with allergic 
asthma. Interestingly, two unrelated studies (  12, 39  ) using an-
other eosinophil-defi  cient strain of mice (i.e.,     dblGATA-1 
[  40  ]) also provide relevant insights supporting the immuno-
regulative roles of eosinophils. Fulkerson et al. (  12  ) reported 
that microarray assessments of lung gene expression in   Asper-
gillus   allergen-challenged     dblGATA-1 mice (relative to 
  allergen-challenged wild-type animals) showed that the absence 
of eosinophils was associated with a signifi  cant reduction 
in pulmonary Th2 gene expression (e.g., IL-4 and IL-13). 
In addition, Voehringer et al. ( 39  ), using    dblGATA  eosinophil-
defi  cient mice and a   Nocardia brasiliensis   mouse model of lung 
infl  ammation, concluded that eosinophils were not required 
for pulmonary T cell recruitment during the primary infection 
of mice. However, eosinophils in this study may be linked 
with a failure to activate/recruit CD4  +   T cells to the lung and, 
in turn, infl   ammatory responses associated with secondary 
challenges with this parasite. Thus, data from both of these 
studies highlight a complexity of pulmonary immune responses 
but again imply a potentially dual role for eosinophils asso-
ciated with the elaboration of secondary immune responses 
in the lung, leading to the proliferation/activation of antigen-
specifi  c T cells and/or subsequent recruitment of these T cells 
to the lung. 
  Finally, there is no reason to assume that either of the 
  eosinophil-mediated eff  ects on T cells outlined in this paper 
methods. The antibody-mediated blockade of TARC and 
MDC in group III mice returned CD4  +   T cell recruitment in 
these   PHIL   animals to the baseline levels observed in   PHIL   
mice from groups I and II (  Fig. 5 C  ). These observations ex-
tended to multiple T cell subsets (e.g., CD4  +  /CD62L      /lo  /
CD44  hi   eff  ector T cells and CD8  +   T cells) that were also dra-
matically reduced in the lungs of anti-TARC/-MDC  –  treated 
group III mice (not depicted). These studies showed that 
T cells are recruited to the lung by the eosinophil-dependent 
production of TARC and MDC and that this induced ex-
pression after allergen challenge is mechanistically linked to 
the T cell recruitment occurring in these mice. 
    DISCUSSION   
  The observation that eosinophils accumulating in the lungs 
after allergen provocation modulate local tissue immune re-
sponses through the specifi  c recruitment of T cells suggests a 
novel mechanism of eosinophil eff  ector function whose sig-
nifi  cance was previously underappreciated. This mechanism 
represents an expansion/extension of earlier studies investi-
gating the potential importance of eosinophils and also pro-
vides an alternative interpretation of data initially noted by 
Lloyd et al. (  26  ). Specifi  cally, we suggest that the expression 
of eotaxins and perhaps other eosinophil agonist factors (e.g., 
leukotriene B  4  ) (  31  ) immediately after allergen challenge 
elicits the recruitment of eosinophils and the expression of 
cytokines and growth factors that also promote eosinophil 
survival and activation. In turn, if and when these accumulat-
ing eosinophils achieve a critical level, their activities pro-
mote the local expression of Th2 chemokines (e.g., TARC 
and MDC) that leads to and/or amplifi  es the recruitment of 
T cells to the lungs and allergen-mediated Th2 infl  ammation. 
Thus, either by a direct (i.e., cell autonomous) or an indirect 
(i.e., induced from a third party cell type) mechanism, infi  l-
trating lung eosinophils may mediate the induction of TARC 
and MDC that elicits the T cell recruitment necessary for 
the infl  ammatory responses associated with mouse models of 
asthma. Interestingly, studies assessing the initial leukocyte 
recruitment to the lungs in both human subjects and mouse 
models of allergic respiratory infl  ammation  demonstrated 
similar kinetic patterns of eosinophil and lymphocyte accu-
mulation into the airways (  32, 33  ), implying that eosinophil-
dependent accumulation of lymphocytes leading to pulmonary 
Th2 infl  ammatory responses may represent a larger, more 
signifi  cant mechanism with implications for asthma patients. 
  Our larger hypothesis linking eosinophils, T cells, and al-
lergic respiratory infl  ammation is that eosinophils mediate the 
recruitment of eff  ector T cells by two apparently indepen-
dent mechanisms: (a) activation and co-stimulation of T cells 
promoting proliferation and/or increased survival, and (b) 
pulmonary production of chemokines that promote the re-
cruitment and/or accumulation of T cells in the lung. It is 
also noteworthy that these eosinophil-dependent mechanisms 
are not mutually exclusive, and each may contribute to the 
loss of Th2 immune responses and pulmonary pathologies in 
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digested for 45 min at 37  °  C, as described previously (  47  ). Single-cell suspen-
sions of lung, spleens, and caudal mediastinal lymph nodes (regional draining 
lymph nodes) were obtained by homogenization with frosted glass slides fol-
lowed by passing through a 40-  μ  m nylon fi  lter to remove larger aggregates 
of cells per tissue. Red blood cells were lysed by ammonium chloride 
(PharmLyse; BD Biosciences). Viability of the cells was   >  95%, as determined 
by Trypan blue exclusion. Cell counts were completed after the last wash 
before staining for fl  ow cytometry. 
  Cytokine assays.     Mouse IL-4, IL-5, IL-13, MDC, and TARC levels were 
assessed using immunoassay kits (R  &  D Systems) according to the manufac-
turer  ’  s instructions. The limits of detection for each cytokine assay were 
5  –  10 pg/ml. 
  Splenocyte culture.     Single-cell suspensions were obtained from sensitized 
and sensitized/challenged   PHIL   and wild-type mice using the protocol 
shown in Fig. S1 A. 10  6   cells/well of splenocytes were cultured in a 96-well 
plate with either media alone, with 200   μ  g/ml OVA (Sigma-Aldrich), or 
with plates precoated with anti-CD3 and -CD28 (BD Biosciences) for 96 h. 
Supernatants were analyzed by ELISA. 
  Flow cytometry analysis.     Single-cell suspensions were stained for 25 min 
on ice with cell type  –  specifi  c antibodies after blockade of Fc receptors using 
1   μ  g/  μ  l of Fc blocker (CD16/32; BD Biosciences). Antibodies used for 
staining specifi  c cell types were obtained from BD Biosciences and include 
the T cell subtype  –  specifi  c antibodies CD3, CD4, CD8, and CD62L, and 
the NK/NKT cell  –  specifi  c marker NK1.1. Additional antibodies represent-
ing other T cell markers (i.e., CD44 and CD25) were purchased from eBio-
science. Propidium iodide staining was used to identify and   “  gate out  ”   
dead cells. Flow cytometry was performed on a cytofl  uorimeter (FACScan; 
Becton Dickinson). Data acquisition and analysis were performed using 
CellQuest Pro (Becton Dickinson) and Sumit (version 4.3; Dako) software. 
  Isolation and polarization of OT-II cells.     Naive OT-II cells were iso-
lated from splenocytes and lymph nodes of 5  –  12-wk-old mice by two 
rounds of positive selection using magnetic beads coupled to the T cell  –
  specifi  c marker CD90  +   (Thy1.2; MACS [Miltenyi Biotec]). 0.5   ×   10  6   puri-
fi  ed CD90  +   T cells/ml were diff  erentiated to the Th2 eff  ector phenotype 
by incubating the cells in RPMI 1640 media (supplemented with 15% FBS 
[HyClone Technologies], 2   ×   10      5   M 2-mercaptoethanol, 1 mM sodium 
pyruvate, 1  ×   nonessential amino acids, 10   μ  g/ml penicillin, 10   μ  g/ml strep-
tomycin, and 2 mM   l-  glutamine; all from Invitrogen) in the presence of 
50   μ  g/ml OVA 323-339 peptide, 8 ng/ml mouse IL-4 (R  &  D Systems), 
5   μ  g/ml anti  –  IL-12 mAb (C17.8; BD Biosciences), and 5   μ  g/ml anti  –  IFN-     
(XMG1.2; BD Biosciences). Irradiated (30 Gy) splenic APCs (depleted of 
CD 90  +   cells) were also added to these cultures (2   ×   10  6   cells/ml). After 
2 d of culture, cells were given 10 ng/ml IL-2 (R  &  D Systems), and on days 
4 and 6 cells were given fresh media with 10 ng/ml of IL-2. After culture 
for a total of 7 d, the recovered Th2-polarized eff  ector T cells were used for 
i.v. injection (1.5   ×   10  7   cells/mouse) into recipient mice. In some experi-
ments, cells were labeled with CFSE, as described by the manufacturer 
(Invitrogen), before injection. FACS analysis reveals   >  98% of cells using 
this method are CD3  +  , with a composition of     85% CD4  +   and     15% 
CD8  +  . Trypan blue exclusion demonstrated   >  98% cell viability. Th2 polar-
ization of this cell population was confi  rmed by ELISA assessments for the 
presence of the Th2 cytokines (i.e., IL-4, IL-5, and IL-13) of 7-d cell-
  culture supernatants. 
  Isolation of mouse eosinophils.     Eosinophils were isolated from IL-5  –
    expressing transgenic mice (NJ.1638) (  30  ), as previously described. In brief, 
peripheral blood pooled from four mice was layered onto single-step Percoll 
gradients. Eosinophils from the buff  y coat at the blood  –  Percoll interface were 
subsequently isolated by removing the contaminating lymphocytes using 
MACS with magnetic beads conjugated with CD45R/B220 (B cells) and 
CD90/Thy1.2 (T cells), according to the manufacturer  ’  s recommendations. 
are necessarily mutually exclusive, and each is likely to con-
tribute to the induced pulmonary immune responses observed 
in eosinophil-suffi   cient wild-type mice. These eosinophil-
  dependent immunoregulatory mechanisms are also not likely 
to be limited to the lung and/or allergen-mediated infl  amma-
tion. That is, the accumulation of tissue eosinophils in a variety 
of settings may represent provocative examples in which 
  eosinophil-mediated expression of Th2 chemokines leads to the 
recruitment of eff  ector T cell recruitment and the modulation 
of local tissue immune cascades. In particular, we suggest that the 
T cell  –  induced immune responses associated with acute rejec-
tion of transplanted organs (  41  ), the onset/growth of tumors 
(  42  ), the accumulation/diff  erentiation of thymic T cell popu-
lations (  43  ), and the immune modulation of the gastrointesti-
nal tract mucosa (  44  ) may ultimately each be causatively linked 
to tissue-specifi  c recruitment of activated eff  ector T cells by 
eosinophils accumulating at these sites. 
  MATERIALS AND METHODS 
  Mice.     All studies were performed with either C57BL/6J wild-type or 
  eosinophil-defi  cient   PHIL   mice (  5  ) crossed to C57BL/6J for   >  10 generations. 
C57BL/6J mice and TCR OVA-transgenic animals on a C57BL/6J back-
ground (OT-II) were purchased from the Jackson Laboratory. The mice 
were maintained in ventilated microisolator cages housed in the specifi  c 
pathogen-free animal facility at the Mayo Clinic Arizona. The sentinel cages 
within the animal colony surveyed negative for the presence of known 
mouse pathogens. Protocols and studies involving animals were performed 
in accordance with National Institutes of Health and Mayo Foundation in-
stitutional guidelines. 
  Acute OVA sensitization and challenge protocols.     Mice were sensi-
tized and challenged with OVA as previously described (  5  ) and outlined in 
Fig. S1 A. The kinetics of leukocyte recruitment to the lungs of sensitized 
and challenged mice were performed as previously described (  33  ) and out-
lined in Fig. S1 B. Studies involving adoptive transfer of T cells derived from 
OVA-specifi  c TCR transgenic mice (OT-II cells) were performed using 
a modifi  cation of a protocol previously described (  45  ) and outlined in 
  Fig. 4 A  . Specifi  cally, on day 0 of this protocol, either PBS or 1.5   ×   10  7   
in vitro Th2-polarized eff  ector T cells (OT-II) were injected i.v. into OVA-naive 
wild-type or   PHIL   mice. Within 3 h of i.v. OT-II cell transfer, the mice 
were gently anesthetized and received an i.n. administration of 20   μ  g OVA 
(1   μ  g/  μ  l in saline). Mice were additionally challenged by i.n. administration 
of OVA on days 1 and 2 of this protocol (i.e., mice were OVA challenged 
via the nasal passages on three consecutive days). In some groups of mice, 
10  7   eosinophils in 20   μ  l of saline were adoptively transferred (control animals 
received saline vehicle alone) via the trachea (i.t.) on days 0, 1, 2, and 3 
of this protocol, and within 1 h after OVA administration on the allergen-
challenge days. OVA-induced responses in these recipient mice were assessed 
on day 4. 
  Collection and diff  erentials of BAL fl  uid  –  derived cells.     BAL assess-
ments were completed as described previously (  5, 46  ). 
  Histology.     Histopathologic changes of the airways were assessed as de-
scribed previously (  5  ). 4-  μ  m formalin-fi  xed, paraffi   n-embedded sections of 
mouse lungs were stained for epithelial cell mucin accumulation using peri-
odic acid Schiff   or, for eosinophils, rabbit polyclonal anti  –  mouse eosinophil 
MBP antiserum (  46  ). 
  Splenocyte, lymph node, and lung cell isolation.     Total pulmonary 
leukocytes were recovered from lungs perfused with PBS-EDTA before 
  removal, placed in complete media with 175 U/ml collagenase IV, and JEM VOL. 205, March 17, 2008 
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Visual examination of Diff  Quick-stained (Dade Behring Inc.) cytospin prep-
arations and by fl  ow cytometry analysis with staining for anti-CCR3 (R  &  D 
Systems) revealed that the purity of these eosinophil preparations was   >  99%. 
  i.t. transfer of eosinophils.     The adoptive transfer of eosinophils and/or 
vehicle control (saline) into the lungs of mice was accomplished in subject 
animals lightly anesthetized with 1% isofl  uorane before i.t. instillation, as de-
scribed previously (  30  ). The transfer of eosinophils (or saline vehicle) was 
completed 1 h after i.n. administration of OVA on days 0, 1, and 2, and at the 
same time of day without OVA on protocol day 3 (  Fig. 4 A  ). 
  Antibody neutralization of MDC and TARC.     Mice were treated with 
antibodies to MDC and TARC with minor modifi  cations of a protocol de-
scribed previously (  48  ). Specifi  cally, 1 h before the OVA challenges, the 
  PHIL   mice received an i.p. injection of either control polyclonal goat IgG 
antibody or 20   μ  g each of polyclonal IgG goat anti-TARC and anti-MDC 
(R  &  D Systems) on days 0, 1, 2, and 3 of the protocol outlined in   Fig. 4 A  . 
  Statistical analysis.     All data were derived from at least three independent 
experiments, each with cohort sizes of two to fi  ve mice. Data presented are 
the means   ±   SE. Statistical analyses were performed using the Student  ’  s   t   test 
with diff  erences between means considered signifi  cant when P   <   0.05. 
  Online supplemental material.     Fig. S1 presents schematic timelines of the 
acute OVA sensitization/aerosol challenge protocols used to elicit allergic re-
spiratory infl  ammation, including the recruitment/accumulation of eosinophils 
and lymphocytes to the lung. Fig. S2 demonstrates that OT-II cells displayed 
the same proliferative capacity after adoptive transfer into eosinophil-suffi   cient 
wild-type and   PHIL   mice. Fig. S3 shows that OT-II cells displayed the same 
T cell surface phenotype after adoptive transfer into eosinophil-suffi   cient 
wild-type and   PHIL   mice. Fig. S4 demonstrates that OVA provocation of 
  PHIL   mice after adoptive transfer of both OT-II cells and eosinophils resulted 
in the development of a BAL eosinophilia and proinfl  ammatory aggregates in 
the peribronchial regions of the lung. Online supplemental material is avail-
able at http://www.jem.org/cgi/content/full/jem.20071840/DC1. 
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